The apolipoprotein B/A-1 ratio in practically healthy participants with normolipidemia
- VernacularTitle:Өөх тосны хэвийн үзүүлэлттэй харьцангуй эрүүл хүмүүсийн аполипопротеин В/ аполипопротеин А-1 харьцааг тодорхойлсон дүн
- Author:
Sodgerel B
1
;
Pilmaa Yo
1
;
Galsumiya L
1
;
Purevsuren D
1
;
Badamsed Ts
1
Author Information
1. Mongolian Institute of Medical Sciences
- Publication Type:Journal Article
- Keywords:
normal lipidemia;
apolipoprotein Apo A-1;
Apo B;
ratio Apo B/Apo A-1;
lipid metabolism
- From:Mongolian Medical Sciences
2019;189(3):3-9
- CountryMongolia
- Language:Mongolian
-
Abstract:
Introduction:Studies demonstrated that the apolipoprotein B/apolipoprotein A-I (Apo B/apo A-I) ratio predicts
cardiovascular risk better than any of the cholesterol indexes. Apo B and Apo A-1 are assumed to be
superiormarkers for lipoprotein abnormalities [1,2]. The concentrations of Apo B and Apo A-1 are associated with cardiovascular disease more strongly than the corresponding lipoprotein cholesterol fractions, the discriminant value of these apoproteins in absolute terms appears to be less important than of their ratio (the Apo B/Apo A-1 ratio) [3, 5-7]. The Apo B/Apo A-1 ratio reflects the balance of atherogenic and antiatherogenic lipoproteins in plasma [4]. Multiple clinical and epidemiological studies have confirmed that the Apo B/Apo A-1 ratio is a superior marker for cardiovascular disease compared with lipids and lipoproteins or their ratios [8, 9].
Goal:We determined the variation limits of the Apo B/Apo A-1 ratio in healthy participants with normolipidemia
and the relationship of this ratio with other lipid parameters.
Material and Methods:A total of 146 normolipidemic healthy participants aged 25–60 years were included in the study.
Anthropometric measurements (height and weight) and other personal information were obtained during the clinical examination and the interview. Participants were included in the study using the following criteria:
1. body mass index < 30 kg/m2;
2. TC < 5.2mmol/L;
3. triglycerides (TG) ≤1.7 mmol/L;
4. HDL-C ≥1.03 mmol/L ( woman), ≥ 1.29 mmol/L (male) .
The plasma levels of total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), apo A-I, Apo B and Apo B/Apo A-1 were determined after a 12 h fasting period. The non-HDL-C was calculated as the difference between the TC and HDL-C. Most research data emphasized that the values for the Apo B/Apo A-1 ratio that define a high cardiovascular risk were proposed to be 0.9 for men and 0.8 for women. Statistical Analysis. The statistical analysis was performed using SPSS 21.0 (USA). Differences between the groups were analyzed using the Mann-Whitney test and the chi-squared test. Correlations between the indices were assessed using
the Spearman’s rank correlation. A value of < 0.05 was accepted as statistically significant.
Results:The relationship of ratio of apolipoprotein (Apo) B/Apo A-1 with other indicators of lipid metabolism in
healthy people with normal lipidemia was analyzed. The Apo B/Apo A-1 ratio in the studied normolipidemic
subjects was 0.69 ± 0.17. The percentage of subjects with the Apo B/Apo A-1 ratio exceeding 0.9 (the
accepted risk value of cardiovascular disease) was 36.3 %.The subjects with Apo B/Apo A-1>0.9 were
characterized by higher HDL-C levels and atherogenic Aпo B, Apo B/Apo A-1 but lower values Apo A-1.
Conclusion:The subjects with normolipidemia the unfavorable Apo B/Apo A-I ratio> 0.9 had more atherogenic lipid
profile.
- Full text:2019-189(3)-3-9.pdf
